![]() |
|
|
Vol. 303, Issue 2, 563-573, November 2002
Geriatric Research, Education, and Clinical Center, Veterans
Affairs Palo Alto Health Care System, Palo Alto, California (Z.-W.H.,
X.-Y.S., T.W.-L., B.B.H.), and the Department of Medicine, Stanford
University School of Medicine, Stanford, California (Z.-W.H., R.K.,
X.-Y.S., T.W.-L., B.B.H.)
In vascular smooth muscle, increased expression of cyclooxygenase-2
(COX-2) has emerged as an important mechanism for regulation of
prostanoid synthesis influenced by vessel injury, cytokines, and growth
factors. We have investigated how COX-2 participates in angiotensin II
(ANG II)-mediated cell responses in cultured human vascular smooth
muscle cells (VSMCs). ANG II type 1 (AT1) receptors induce increased
accumulation of COX-2, both at the mRNA and protein levels. ANG II
increased transcription of the COX-2 gene; also, nuclear extracts from
stimulated cells had increased NF-
B binding to its DNA
consensus sequence. ANG II-induced COX-2 expression was markedly
blunted by inhibition of mitogen-activated protein kinase. Furthermore,
the ANG II-induced increase in COX-2 protein abundance was attenuated
by both the peroxisome proliferator-activated receptor
(PPAR
) activator Wy-14,643 [pyrinixic acid;
4-chloro-6-(2,3-xylidino)-2-pyrimidinyl) thioacetic acid] and the
PPAR
activator 15d-PGJ2
(15-deoxy-
12-14-prostaglandin J2). Not only did
ANG II increase COX-2 expression and prostaglandin synthesis, ANG
II-stimulated DNA synthesis and cell migration were dependent on COX-2
activity. PPAR
and PPAR
activators inhibited ANG II-stimulated
DNA synthesis and cell migration. These results suggest that ANG
II enhances COX-2 expression at the transcription level; also, COX-2
activity plays an important role in mediating ANG II- induced
proliferation and migration of VSMCs, suggesting the possibility of
magnification of ANG II effects over time due to the induction of COX-2
expression. These results also demonstrate that both the
and
type of PPAR activators inhibit COX-2 expression induced by angiotensin
II in VSMCs which may have therapeutic significance in vascular diseases.
This article has been cited by other articles:
![]() |
Y. Alvarez, J. V. Perez-Giron, R. Hernanz, A. M. Briones, A. Garcia-Redondo, A. Beltran, M. J. Alonso, and M. Salaices Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 381 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Morinelli, J. R. Raymond, A. Baldys, Q. Yang, M.-h. Lee, L. Luttrell, and M. E. Ullian Identification of a putative nuclear localization sequence within ANG II AT1A receptor associated with nuclear activation Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1398 - C1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zahradka, B. Wright, M. Fuerst, N. Yurkova, K. Molnar, and C. G. Taylor Peroxisome Proliferator-Activated Receptor {alpha} and {gamma} Ligands Differentially Affect Smooth Muscle Cell Proliferation and Migration J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 651 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1137 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rodriguez, P. De la Cerda, E. Collyer, V. Decap, C. P. Vio, and V. Velarde Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H30 - H36. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, W. Su, S. Allen, H. Pang, A. Daugherty, E. Smart, and M. C. Gong COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice Cardiovasc Res, September 1, 2005; 67(4): 723 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J.E. Sattler, J. E. Woodrum, O. Galili, M. Olson, S. Samee, F. B. Meyer, X.-Y. Zhu, L. O. Lerman, and A. Lerman Concurrent Treatment With Renin-Angiotensin System Blockers and Acetylsalicylic Acid Reduces Nuclear Factor {kappa}B Activation and C-Reactive Protein Expression in Human Carotid Artery Plaques Stroke, January 1, 2005; 36(1): 14 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Whalin and W. R. Taylor Rounding up the usual suspects in atherosclerosis. Focus on "Growth factors induce monocyte binding to vascular smooth muscle" Am J Physiol Cell Physiol, September 1, 2004; 287(3): C592 - C593. [Full Text] [PDF] |
||||
![]() |
Q. Cai, L. Lanting, and R. Natarajan Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis Am J Physiol Cell Physiol, September 1, 2004; 287(3): C707 - C714. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Drenjancevic-Peric and J. H. Lombard Introgression of chromosome 13 in Dahl salt-sensitive genetic background restores cerebral vascular relaxation Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H957 - H962. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, T. Chabrashvili, and C. S. Wilcox Enhanced Contractility of Renal Afferent Arterioles From Angiotensin-Infused Rabbits: Roles of Oxidative Stress, Thromboxane Prostanoid Receptors, and Endothelium Circ. Res., June 11, 2004; 94(11): 1436 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang, S. Xu, X. Hou, D. R. Pimentel, and R. A. Cohen Angiotensin II Differentially Regulates Interleukin-1-{beta}-inducible NO Synthase (iNOS) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression: ROLE OF p38 MAPK J. Biol. Chem., May 7, 2004; 279(19): 20363 - 20368. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cipollone, B. Rocca, and C. Patrono Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 246 - 255. [Abstract] [Full Text] |
||||
![]() |
C. Bregonzio, I. Armando, H. Ando, M. Jezova, G. Baiardi, and J. M. Saavedra Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G414 - G423. [Abstract] [Full Text] [PDF] |
||||